Quick Details
- Processing Time:3-30 days
- Port:Beijing
- Supply Ability: 1000000000 Pieces Per Year
- Brand Name:Sinovac
Sinovac COVID-19 vaccine is based on inactivated whole virion technology.
Sinovac COVID-19 vaccine have been used more than 1 million doses safely in many countries including China, Brazil, Chile, Indonesia, Turkey.
Phase III was approved by Brazil authority on July 3, and has started on July 21, 2020.
Started in Indonesia on 11th Aug, 2020.
Also approved by Turkey and Bangladesh.
Efficacy result on rhesus model published in Science on May 6, 2020.
Phase I/II was commenced on April 16, and May 3, 2020.
Phase I/II trials were approved by NMPA on April 13, 2020.
Initial R&D of CIVID-19 vaccine on Jan 28, 2020.
WhatsApp +86 13808997462
